Geertruida E. Romeijn

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis.

Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis.

Journal: JAMA dermatology

Published: August 07, 2024

The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.

The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.

Journal: The British journal of dermatology

Published: September 06, 2023

Effectiveness of antibacterial therapeutic clothing vs. nonantibacterial therapeutic clothing in patients with moderate-to-severe atopic dermatitis: a randomized controlled observer-blind pragmatic trial (ABC trial).

Effectiveness of antibacterial therapeutic clothing vs. nonantibacterial therapeutic clothing in patients with moderate-to-severe atopic dermatitis: a randomized controlled observer-blind pragmatic trial (ABC trial).

Journal: The British journal of dermatology

Published: July 12, 2023

Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire.

Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire.

Journal: The British journal of dermatology

Published: May 16, 2023

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis.

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis.

Journal: Clinical and translational allergy

Published: January 27, 2023

Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviews.

Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviews.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 25, 2022

Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.

Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.

Journal: Contact dermatitis

Published: September 23, 2022

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry.

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: August 19, 2022

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry.

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry.

Journal: JAMA dermatology

Published: August 10, 2022

Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.

Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 05, 2022

Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.

Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.

Journal: Allergy

Published: May 05, 2022

Efficacy and safety of oral alitretinoin versus oral azathioprine in patients with severe chronic hand eczema: Results from a prematurely discontinued randomized controlled trial.

Efficacy and safety of oral alitretinoin versus oral azathioprine in patients with severe chronic hand eczema: Results from a prematurely discontinued randomized controlled trial.

Journal: Contact dermatitis

Published: April 26, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026